Ergang Wang

627 total citations
9 papers, 181 citations indexed

About

Ergang Wang is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ergang Wang has authored 9 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ergang Wang's work include Pregnancy and preeclampsia studies (1 paper), Autophagy in Disease and Therapy (1 paper) and Plant Gene Expression Analysis (1 paper). Ergang Wang is often cited by papers focused on Pregnancy and preeclampsia studies (1 paper), Autophagy in Disease and Therapy (1 paper) and Plant Gene Expression Analysis (1 paper). Ergang Wang collaborates with scholars based in United States, China and Singapore. Ergang Wang's co-authors include Kun Xiang, Yun Zhang, Xiao‐Fan Wang, Xiao‐Fan Wang, Jen‐Tsan Chi, Anna Mae Diehl, Raquel Maeso‐Díaz, Kuo Du, Christopher S. Pan and Rajesh Kumar Dutta and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Ergang Wang

9 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ergang Wang United States 7 65 41 33 32 31 9 181
Gaili Ji China 7 73 1.1× 16 0.4× 38 1.2× 34 1.1× 25 0.8× 17 179
Hiromi Chikada Japan 8 173 2.7× 49 1.2× 46 1.4× 12 0.4× 26 0.8× 12 302
Robert Habib United Kingdom 5 158 2.4× 22 0.5× 70 2.1× 37 1.2× 20 0.6× 12 225
Tamsin R.M. Lannagan United Kingdom 7 75 1.2× 58 1.4× 34 1.0× 32 1.0× 17 0.5× 20 186
Berk Aykut United States 4 63 1.0× 24 0.6× 9 0.3× 28 0.9× 26 0.8× 7 167
Emiliano Pasquini Italy 4 141 2.2× 47 1.1× 41 1.2× 27 0.8× 38 1.2× 6 237
Xiaoran Zhang China 10 240 3.7× 11 0.3× 41 1.2× 15 0.5× 27 0.9× 18 298
Amruta Bhate United States 7 230 3.5× 26 0.6× 53 1.6× 28 0.9× 27 0.9× 7 310
Saiyan Bian China 10 231 3.6× 51 1.2× 109 3.3× 22 0.7× 38 1.2× 18 292
Hubert Y. Luu United States 6 141 2.2× 58 1.4× 32 1.0× 14 0.4× 97 3.1× 11 409

Countries citing papers authored by Ergang Wang

Since Specialization
Citations

This map shows the geographic impact of Ergang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ergang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ergang Wang more than expected).

Fields of papers citing papers by Ergang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ergang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ergang Wang. The network helps show where Ergang Wang may publish in the future.

Co-authorship network of co-authors of Ergang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ergang Wang. A scholar is included among the top collaborators of Ergang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ergang Wang. Ergang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Tan, Lianmei, Tao Yin, Handan Xiang, et al.. (2024). Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response. Nature Communications. 15(1). 8569–8569. 10 indexed citations
3.
Zhu, Xiaoyi, Qiang Huang, Laiming Jiang, et al.. (2024). Longitudinal intravital imaging of mouse placenta. Science Advances. 10(12). eadk1278–eadk1278. 25 indexed citations
4.
Du, Kuo, Raquel Maeso‐Díaz, Ergang Wang, et al.. (2023). Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis. Hepatology. 77(6). 1998–2015. 60 indexed citations
5.
Liang, Yaosi, Christopher C. Pan, Tao Yin, et al.. (2023). Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype. Advanced Science. 11(2). e2303489–e2303489. 13 indexed citations
6.
Gadgeel, S., Ergang Wang, A. Srikantha Phani, et al.. (2023). EP12.01-64 Metastatic Non-Small Cell Lung Cancer With EGFR Mutations: Treatment Pattern and Outcomes From a Systematic Literature Review. Journal of Thoracic Oncology. 18(11). S667–S667. 1 indexed citations
7.
Wang, Ergang, Kun Xiang, Yun Zhang, & Xiao‐Fan Wang. (2022). Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models. SHILAP Revista de lepidopterología. 2(4). 263–276. 35 indexed citations
8.
Wang, Lihua, Ergang Wang, Yi Wang, et al.. (2018). miR-34a is a microRNA safeguard for Citrobacter-induced inflammatory colon oncogenesis. eLife. 7. 29 indexed citations
9.
Lacelle, Chantale, et al.. (2002). Blood-Sample Processing for the Study of Age-Dependent Gene Expression in Peripheral Blood Mononuclear Cells. The Journals of Gerontology Series A. 57(7). B285–B287. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026